Mechanism of action and treatment of type I interferon in hepatocellular carcinoma

被引:5
作者
Peng, Chunxiu [1 ]
Ye, Zhijian [1 ]
Ju, Ying [1 ]
Huang, Xiuxin [1 ]
Zhan, Chenjie [1 ]
Wei, Ke [1 ]
Zhang, Zhiyong [1 ]
机构
[1] Guangxi Med Univ, Natl Ctr Int Res Biotargeting Theranost, Collaborat Innovat Ctr Targeting Tumor Diag & Ther, Guangxi Key Lab Biotargeting Theranost,State Key L, Nanning 530021, Guangxi, Peoples R China
关键词
Hepatocellular carcinoma; Hepatitis B virus; Hepatitis C virus; Interferon-& beta; Interferon-& alpha; Type I interferon; FATTY LIVER-DISEASE; MESSENGER-RNA; STIMULATED GENES; DNA-DAMAGE; CELLS; BETA; SORAFENIB; CANCER; ALPHA; PROGRESSION;
D O I
10.1007/s12094-023-03266-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) caused by HBV, HCV infection, and other factors is one of the most common malignancies in the world. Although, percutaneous treatments such as surgery, ethanol injection, radiofrequency ablation, and transcatheter treatments such as arterial chemoembolization are useful for local tumor control, they are not sufficient to improve the prognosis of patients with HCC. External interferon agents that induce interferon-related genes or type I interferon in combination with other drugs can reduce the recurrence rate and improve survival in HCC patients after surgery. Therefore, in this review, we focus on recent advances in the mechanism of action of type I interferons, emerging therapies, and potential therapeutic strategies for the treatment of HCC using IFNs.
引用
收藏
页码:326 / 337
页数:12
相关论文
共 96 条
  • [11] Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases
    Crabb, David W.
    Im, Gene Y.
    Szabo, Gyongyi
    Mellinger, Jessica L.
    Lucey, Michael R.
    [J]. HEPATOLOGY, 2020, 71 (01) : 306 - 333
  • [12] SUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response
    Crowl, John T.
    Stetson, Daniel B.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (26) : 6798 - 6803
  • [13] Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing
    Decque, Adrien
    Joffre, Olivier
    Magalhaes, Joao G.
    Cossec, Jack-Christophe
    Blecher-Gonen, Ronnie
    Lapaquette, Pierre
    Silvin', Aymeric
    Manel, Nicolas
    Joubert, Pierre -Emmanuel
    Seeler, Jacob-Sebastian
    Albert, Matthew L.
    Amit, Ido
    Amigorena, Sebastian
    Dejean, Anne
    [J]. NATURE IMMUNOLOGY, 2016, 17 (02) : 140 - 149
  • [14] Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
    Der, SD
    Zhou, AM
    Williams, BRG
    Silverman, RH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15623 - 15628
  • [15] Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
    Dixon, Scott J.
    Lemberg, Kathryn M.
    Lamprecht, Michael R.
    Skouta, Rachid
    Zaitsev, Eleina M.
    Gleason, Caroline E.
    Patel, Darpan N.
    Bauer, Andras J.
    Cantley, Alexandra M.
    Yang, Wan Seok
    Morrison, Barclay, III
    Stockwell, Brent R.
    [J]. CELL, 2012, 149 (05) : 1060 - 1072
  • [16] Dong HD, 1999, NAT MED, V5, P1365
  • [17] ISG15-Induced IL-10 Is a Novel Anti-Inflammatory Myeloid Axis Disrupted during Active Tuberculosis
    dos Santos, Paula Fernandes
    Van Weyenbergh, Johan
    Delgobo, Murilo
    Patricio, Daniel de Oliveira
    Ferguson, Brian J.
    Guabiraba, Rodrigo
    Dierckx, Tim
    Menezes, Soraya Maria
    Bafica, Andre
    Mansur, Daniel Santos
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (04) : 1434 - 1442
  • [18] Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression
    Du, Li
    Liu, Wei
    Rosen, Steven T.
    Chen, Yuan
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2023, 435 (05)
  • [19] Siglecs as Immune Cell Checkpoints in Disease
    Duan, Shiteng
    Paulson, James C.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, VOL 38, 2020, 38 : 365 - 395
  • [20] Racial Differences in the Progression to Cirrhosis and Hepatocellular Carcinoma in HCV-Infected Veterans
    El-Serag, Hashem B.
    Kramer, Jennifer
    Duan, Zhigang
    Kanwal, Fasiha
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (09) : 1427 - 1435